Status:

COMPLETED

Distribution of Rubidium-82, Nitrogen-13 Ammonia, and Fluorine-18 Fluorodeoxyglucose in Normal Volunteers

Lead Sponsor:

University of Michigan

Conditions:

Heart Disease

Eligibility:

All Genders

30-70 years

Phase:

PHASE1

Brief Summary

Establish the normal distributions of Rb-82, N-13 ammonia, and F-18 FDG (radioactive tracers) in the heart using PET imaging. These tracers would be eventually used in evaluating the hearts of patient...

Detailed Description

Cardiac rubidium-82(Rb-82)and N-13 ammonia heart perfusion (blood flow) studies and florine-18 fluorodeoxyglucose (F-18FDG) heart PET glucose metabolism studies are important tools for evaluating pati...

Eligibility Criteria

Inclusion

  • Healthy normal volunteers

Exclusion

  • Prior participation in a study with significant radiation exposure
  • Significant radiation exposure for other reasons, example: routine medical care
  • Medical history of physical or treadmill exercise stress EKG evidence of heart or vascular disease.
  • Cardiac A-V conduction abnormalities
  • Diabetes Mellitus
  • Liver Disease
  • Kidney Disease
  • Other chronic debilitating illnesses ( Example: Rheumatoid Arthritis, Emphysema, Parkinson's Disease).
  • Tobacco use, hypertension, diabetes, family history of coronary artery disease before age 45 in males and 55 in females or other coronary risks factors of more than mild severity
  • Claustrophobia (fear of tight spaces)
  • Pregnancy
  • Inability to lay flat with your arms positioned next to your head for approximately 20 minutes.
  • Morbid Obesity
  • Asthma
  • Breasts Implants
  • Use of anabolic steroids
  • Use of recreational drugs

Key Trial Info

Start Date :

November 1 2011

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

January 19 2018

Estimated Enrollment :

70 Patients enrolled

Trial Details

Trial ID

NCT01433705

Start Date

November 1 2011

End Date

January 19 2018

Last Update

January 30 2019

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

University of Michigan Hospital

Ann Arbor, Michigan, United States, 48109